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Abstract
Background: Sub-Saharan Africa is increasingly being challenged in providing care and treatment for chronic
diseases, both communicable and non-communicable. In order to address the challenges of linkage to and
retention in chronic disease management, there is the need to understand the factors that can influence
engagement in care. We conducted a qualitative study to identify barriers and facilitators to linkage and retention
in chronic care for HIV, tuberculosis (TB) and Hypertension (HTN) as part of the Academic Model Providing Access
to Healthcare (AMPATH) program in western Kenya.
Methods: In-depth interviews and focus group discussions were conducted July 2012-August 2013. Study participants
were purposively sampled from three AMPATH clinics and included patients within the AMPATH program receiving
HIV, TB, and HTN care, as well as caregivers of children with HIV, community leaders, and healthcare providers. A set of
interview guides were developed to explore perceived barriers and facilitators to chronic disease management,
particularly related to linkage to and retention in HIV, TB and HTN care. Data were coded and various themes were
identified. We organized the concepts and themes generated using the Andersen-Newman Framework of Health
Services Utilization.
Results: A total of 235 participants including 110 individuals living with HIV (n = 50), TB (n = 39), or HTN (n = 21); 24
caregivers; 10 community leaders; and 62 healthcare providers participated. Barriers and facilitators were categorized as
predisposing characteristics, enabling resources and need factors. Many of the facilitators and barriers reported in this
study were consistently reported across disease categories including personal drive, patient-provider relationships and
the need for social and peer support.
Conclusions: Our findings provide insight into the individual as well as broader structural factors that can deter or
encourage linkage and retention that are relevant across communicable and non-communicable chronic diseases. The
findings of the present study suggest that interventions should consider the logistical aspects of accessing care in
addition to predisposing and need factors that may affect an individuals’ decision to seek out and remain in
appropriate care.
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Background
Chronic diseases are on the rise in sub-Saharan Africa,
in part because of improvements in life expectancy and
better control of previously terminal illnesses such as
HIV [1–4]. In Kenya, approximately 7.1 % of the popula-
tion is living with HIV and HIV/TB co-infection is esti-
mated to affect 48 % of new TB patients. However,
NCDs are increasingly accounting for a higher propor-
tion of national morbidity and mortality in Kenya [5].
Given the weak healthcare infrastructure and more trad-
itional health-seeking behaviors of patients which have
been primarily focused on treatment of acute disease,
chronic diseases are presenting new and significant chal-
lenges to both patients and healthcare providers [4, 6, 7].
At the same time, people living with chronic infectious
diseases including HIV and TB are already at risk for de-
veloping additional co-morbidities including non-
communicable diseases [8].
When chronic diseases like HIV and hypertension
(HTN) are left untreated, there is an increased risk of
morbidity and mortality [9–12]. Furthermore, while
TB is treatable, it can also be a chronic illness and
scarring can be permanent [13]. In response to the
rise of multiple co-morbidities, integrated care has
become increasingly important [8, 14, 15]. While HIV,
TB and HTN have different modes of transmission
and associated risk factors [14], they also share cer-
tain characteristics including the need for consistent
engagement in care. Given the need for regular
follow-up, the establishment and maintenance of
stable and consistent relationships between patients
and the healthcare system is needed [14].
For most chronic illnesses, successful engagement in
the continuum of care begins with testing and diagnosis,
linkage into care followed by retention over the time.
While initial linkage into care following testing is a cru-
cial stage in the care continuum, many individuals are
never successfully linked and thus may never receive the
treatment, care and support they need. In our
population-based setting, we found that while engage-
ment in HIV care was high among those who were pre-
viously known to be HIV-positive, only 16 % of those
newly diagnosed through home-based testing and coun-
selling for HIV had linked to care during a median of
3 years [16]. Studies from other settings have also dem-
onstrated poor linkage rates following testing [17–20].
In a recent study in South Africa, linkage rates for TB
and hypertension were estimated at 52 and 50 % respect-
ively suggesting that almost half of those screened do
not link to care [21]. Not engaging in care following test-
ing is a major missed opportunity for maximizing health
outcomes, reducing morbidity and mortality, and min-
imizing ongoing transmission, in the case of communic-
able diseases such as HIV and TB [22, 23]. Additionally,
once linked, continuous retention in chronic disease care
is challenging for many. In the case of HIV, a systematic
review demonstrated that retention in care at 36 months
averages between 65–70 % [24] with attrition being
mainly a result losses to follow-up. While there is a
dearth of information available for retention in hyperten-
sion care programs, we do know that treatment success
rates for TB remain poor with approximately 28 % of pa-
tients reported as lost to follow up [13].
To effectively address the challenges related to chronic
disease management related to timely linkage and reten-
tion of patients, there is an urgent need to identify and
understand the barriers and facilitators that pose chal-
lenges to engagement across various socio-cultural envi-
ronments and disease categories. The latter is
particularly important in the context of the increasing
number of people living with HIV who are also living
with co-morbid conditions [8, 25] and if the public
health impact of earlier screening and diagnosis will be
fully realized [13, 21]. We therefore conducted a qualita-
tive study to explore the perspectives of patients, care-
givers, and health care providers on engagement in
chronic care for HIV, TB and HTN. Specifically, we ex-
plored common barriers and facilitators to linkage and
retention in chronic disease care among patients cur-
rently enrolled in the Academic Model Providing Access
to Healthcare (AMPATH) program in western Kenya.
Methods
Study Setting- The Academic Model Providing Access to
Healthcare (AMPATH) program
The AMPATH program, headquartered in Eldoret,
Kenya (about 350 km north-west of Nairobi) was initi-
ated in 2001 as a joint partnership between Moi Univer-
sity School of Medicine, Moi Teaching and Referral
Hospital (MTRH) [26, 27], and a consortium of North
American universities led by Indiana University (IU)
School of Medicine. The history, organizational struc-
ture, and health programs of AMPATH have been de-
scribed elsewhere [28]. AMPATH provides technical
support, mentorship and training to Kenyan medical fac-
ulty and staff with the aim of developing healthcare ser-
vices in Kenya. AMPATH delivers care, provides
education, and performs research in networks of urban
and rural Ministry of Health hospitals, health centers,
and dispensaries in western Kenya. AMPATH currently
follows >85,000 HIV-positive patients in 22 sub-counties
of 8 counties in western Kenya. All HIV and TB-related
care and treatment are free at the point of service for pa-
tients. Patients are managed according to National Ken-
yan protocols, which are consistent with WHO
guidelines. While AMPATH initially focused on patients
infected with HIV, it has since expanded to provide ma-
ternal and child health services and chronic disease
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management, including diabetes and hypertension, to a
catchment population of over 2 million persons [29, 30].
This study was undertaken in three AMPATH sites,
namely Turbo, Teso, and Chulaimbo (Fig. 1).
Target population
In order to gain additional perspectives on challenges to
linkage and retention in care, we sought to include a
broad range of participants including patients, commu-
nity members and healthcare providers. More specific-
ally, this study targeted patients within the AMPATH
program including patients receiving HIV, TB, and
hypertension care, as well as caregivers of children with
HIV, community leaders (religious leaders, traditional
healers, village elders, assistant chiefs), community
health workers (CHWs), para-clinical staff (Nutritionist,
Psychosocial, Outreach, Social work teams) and health-
care providers (nurses, clinical officers, medical officers).
Study design
This was an exploratory qualitative study conducted be-
tween July 2012 and August 2013. Study participants
were purposively sampled from three ethnically and geo-
graphically diverse AMPATH sites. In-depth interviews
(n = 16) and focus group discussions (FGDs, n = 26) were
used to collect data (See Table 1). The number of data
collections was predetermined based on conventional
guidelines that each sub-population of the study had a
minimum of two sessions. Theoretical saturation was as-
sumed based on the number of sessions completed per
population. FGDs were held separately for each partici-
pant group and for men and women among patient
groups with the exception of HTN and TB FGD which
were mixed in Teso. A set of interview guides were de-
veloped to explore perceived barriers and facilitators to
chronic disease management particularly for linkage and
retention to HIV, TB and HTN care (See attached
guides). Specific questions were asked about barriers and
facilitators to linkage versus those related to retention
and individually for each chronic disease of interest. In
addition, basic socio-demographic information of age,
gender, educational level and occupation was collected.
Trained research assistants identified the target groups
at AMPATH health facilities and informed them about
the study. Health facility in-charges assisted with con-
tacting the participants. Data collection was conducted
by members of the research team at the Social Behav-
ioral Team within AMPATH. While some respondents
(e.g., AMPATH staff ) knew of some members of the re-
search team and understood that there was a need to in-
form the care program particularly related to chronic
disease management, given the physical distance be-
tween AMPATH headquarters and the three rural sites,
there was no prior relationship between participants and
the researchers. The interview sessions and FGDs took
approximately 1 h and were conducted in English, Swa-
hili, Kalenjin, or Luo. All sessions were audio recorded
and for the FGDs, scribes also took notes on session
proceedings. At the end of each session participants
were provided with transport reimbursement of 200
Kenyan Shillings (approximately $2.50 US). This re-
search was program driven and was situated within the
broader AMPATH Care Program with the goal of im-
proving linkage and retention of patients within existing
clinics. It was considered a low-risk rapid appraisal. Ver-
bal consent was obtained prior to beginning data collec-
tion and again prior to commencing audio recording.
While consent forms were not used, transcripts from the
FGDs and in-depth interviews demonstrate agreement
and consent to proceed with the data collection. For
Fig. 1 Map of Study Sites: This figure presents a map of all AMPATH sites in western Kenya and specifically highlights the three study sites:
Chulaimbo, Teso and Turbo
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patients participating in FGD, they did not have to dis-
close the chronic disease status given that most partici-
pants knew each other’s conditions for they were
recruited from specialty clinics that were caring for spe-
cific conditions. FGD were utilized only for patient
groups as they were considered a more homogenous
group. In-depth interviews were held with community
leaders and provider groups only as they were consid-
ered a more heterogeneous group that was purposely se-
lected based on their unique and comprehensive
knowledge on the topics relevant for the present study.
Finally, it is worth noting that his study was situated
within a larger AMPATH Program protocol. Note that
ethical approval for this study was obtained through an
amendment of a larger AMPATH Program protocol that
received ethical approval from the Institutional Research
and Ethics Committee (IREC) of Moi University College
of Health Sciences and Moi Teaching and Referral Hos-
pital as well as the Indiana University Institutional Re-
view Board (IRB).
Data analysis
Recorded interviews and FGDs were transcribed and
translated to English. The data were then coded and
themes related to barriers and facilitators to HIV, TB
and HTN linkage and retention were identified. Induct-
ive and deductive data analysis approaches were used.
Ideas from different interviews were pooled together and
integrated into common themes. Concepts from these
themes were generated and we used a conceptual model
based on the Andersen-Newman Framework of Health
Services Utilization to organize the presentation of the
results. In the Andersen Newman Framework (Fig. 1),
an individual’s access to and use of healthcare is a func-
tion of three main factors: 1) Predisposing Characteris-
tics (socio-cultural characteristics of individuals that
exist prior to their illness); 2) Enabling Resources (the
logistical aspects of obtaining care, which can include
personal, family and community resources); and 3) Need
Factors (the most immediate cause of healthcare use
from problems that generate the need for care) [31]. For
validation, independent coding and identification of
themes were conducted by five investigators. We started
with a codebook that had a priori codes that were de-
rived from the original question guide. The 5 investiga-
tors (VN, JW, RK, JO, BK), all women, worked
independently to identify emerging inductive codes that
were then added to the codebook as necessary although
data was also interpreted based on pre-existing know-
ledge about the context, the study objectives and the
identified themes. Training relating to qualitative data
analysis including coding and thematic analysis was also
provided. As well, all investigators involved in coding
and interpretation had extensive experience in qualita-
tive research methods. Of the investigators involved in
coding and analysis, two have PhDs (1 in Sociology and
1 in Human Behavior) and three have Bachelor’s degree
(2 in sociology and 1 in nutrition). The original code-
book was created in unison (all 5 investigators were in-
volved). The number of interviews were divided evenly
among the 5 investigators. Each coder highlighted area
of discrepancies and then met as a group to harmonize a
response. Note that no software was used. The final




A total of 235 participants including 110 individuals liv-
ing with HIV (n = 50), TB (n = 39), or hypertension (n =
21); 24 caregivers; 10 community leaders; and 62 health-
care providers including community health workers (n =
28) participated in the study. There were no refusals to
participate.
Based on the Anderson-Newman Framework of
Health Services Utilization, barriers and facilitators were
organized into three main categories: predisposing char-
acteristics, enabling resources and need factors. Enabling
Table 1 Participant Characteristics*
Site PLWHA HTN TB Caregiver CHWS Safety Nets HCP
Men Women Men Women Men Women Mixed Mixed Mixed Mixed
Turbo 1 1 1 1 1 1 1 1 1 1
Teso 1 1 1 (mixed) 1 (mixed) 1 1 1 1
Chulaimbo 1 1 - 1 1 1 1 1
Site Religious leader Traditional healers AMPATH/PHC in-charge MOH in-charge Village elder/assistant chief
Turbo 1 1 1 1 1
Teso 1 1 1 1 1
Chulaimbo 1 2 1 1 1
*PLWHA People Living With HIV/AIDS, HTN Hypertensive Patients, TB TB Patients, Caregiver for children living with HIV, CHWSCommunity Health Workers, Safety
Nets includes nutritionists, outreach workers, social workers, psychosocial workers; HCP = Healthcare providers including clinical officers, nurses, pharmacists and
lab technicians
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resources (as barriers and facilitators) were most com-
monly reported. Most were common to both linkage
and retention (described below) although there were
some differences (e.g., Lack of Acceptance was reported
as a barrier to linkage only; Media/peer influences a bar-
rier to retention only) (Tables 2 and 3). Most barriers
and facilitators were reported for HIV. See Tables 2 and
3 for list of barriers and facilitators for linkage and re-
tention across disease categories.
Barriers common to linkage and retention
Predisposing characteristics
Predisposing characteristics consisted of factors related
to knowledge, attitudes and beliefs that hindered linkage
and retention. While the majority of barriers were re-
ported for linkage to and retention in HIV care, several
barriers were commonly reported across disease categor-
ies and were common across linkage and retention.
Poor motivation was reported as a barrier to linkage
and retention and was reported across all disease cat-
egories. Issues related to hopelessness and feeling tired
were particularly challenging for retention. As one care-
giver noted: “Some people just get tired of taking their
drugs and if there is no improvement in health, some
may give up” (Caregiver, Turbo). Another participant
further elaborated: “…let us take an example of these
sexual workers, they are still having unprotected sex and
all that so they get new strains of the virus…through that
they take drugs but there is no change then they say, ‘I
have been taking these drugs for more than a year now
but there is no change, so what is the need for me to con-
tinue using the drugs” So they stop using them” (HCP,
Chulaimbo). Related to this is forgetfulness which was re-
ported as a barrier to linkage and retention for HIV and
HTN but not TB: “We tend to forget that when we feel
better after a while, we are cured…its human nature”
(Community Leader, Chulaimbo). “The other thing is
laziness, when someone has gone to bed and has not
taken drugs for example, one will feel too lazy to get up
and take the drugs (all laugh) or they forget to take
them” (HTN FGD participant, Turbo”).
A lack of knowledge and/or understanding around the
need to engage in care also is a barrier to linkage and re-
tention. “…Someone may buy pain killers and feel much
better and think they are OK. So if you tell such a person
to go to the hospital, they’ll always procrastinate.” (HTN
FGD participant, Turbo). An HIV positive patient noted
that: “Even when they come for treatment, they expect a
quick recovery. But they don’t understand that this is a
lifetime treatment. Because of this, they go back and
don’t stop coming” (PLWH FGD participant, Turbo).
Again, this relates closely to lack of knowledge about the
need to take medications: “Somebody might be given a
return date to go and monitor progress, when the
condition improves he/she says, “Why should I go back to
the doctor?” (Religious Leader, Teso). Fear of taking
drugs can also act as a major barrier to both linkage and
retention. In terms of linkage to HIV, for example, one
PLWH noted: “there are some who fear coming for
‘andila’ (the name given to ARVs in the village) because
they heard that once you start taking them, you can’t
stop for the rest of your life…” (PLWH FGD participant,
Chulaimbo).
Many have preferences in alternative medicine. This
was reported as a barrier to linkage for HIV and TB and
all disease categories for retention. This may stem from
fear of the medications themselves. “Take medicines for
a very long time but no sign of improvement, a person
gives up or tries alternative medicine like herbal medi-
cine” (CHW FGD participant, Teso). Preferences for al-
ternative forms of care may also be influenced by
outside forces but can also be reflective of poor treat-
ment literacy (e.g., understanding the need to adhere to
appropriate medicines). For example, “…advertisement
may put across very appealing message that there is a
doctor who has medicine that if you take for two weeks
you be back to normal than these other conventional
medicine” (CHW FGD participant, Teso). The use of al-
ternative forms of care may result in poor outcomes par-
ticularly when individuals fail to engage with appropriate
care: “There are people who are positive but have been
brainwashed by herbal medicines. They are told herbs
cure HIV so they dispose of their ARVs and use them.
Some die due to this” (Caregiver FGD participant,
Turbo).
The use of alcohol/drugs was reported as a barrier.
While misuse was reported for HIV linkage, it was a
common barrier in terms of retention: “They are told
not to drink and take their medicine. They drink and for-
get or at times take their medicines while drunk” (Com-
munity Leader, Chulaimbo). Another participant noted:
“One might stop taking their medication and resort to al-
cohol. …He does not have the time to come to the hos-
pital or take his medication” (TB FGD participant,
Chuliambo).
Cultural beliefs and social norms that can negatively
impact linkage and retention were also described: “cul-
tural issues such as a mother in-law and a son-in law
being in the same queue” (HCP, Teso). Related to this
are religious beliefs: “These pastors tell people that you
will be healed through prayers. A patient is told that you
have been prayed for, so do not go back for those” (HCP,
Teso). Beliefs that their illnesses are a result of witch-
craft were also described as a key barrier: “…some symp-
toms are associated with witchcraft for example, a curse
and they know that the symptoms can only be cured with
certain systems …say church, if you are bewitched you
probably need to see a sorcerer or something like that.
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Table 2 Barriers to Linkage and Retention to HIV, HTN and TB care
Linkage Retention
HIV HTN TB HIV HTN TB
Predisposing Characteristics
Lack of acceptance of status X X
Forgetfulness X X X X
Poor motivation X X X X X X
Lack of knowledge X X X X X X
Fear of taking drugs/expectations of treatment X X X X X
Preference in alternative medicine X X X X X
Older age/male gender X X
Alcohol use/drug use X X X X
Patient attitudes to care/expectations of AMPATH X
Couple/family conflicts X X
Promiscuity X X
Cultural beliefs (e.g., association with witchcraft) X X X
Disclosure X
Enabling Resources
Perceived stigma X X X X X
Relocation X X X
Lack of finances/transport/food X X X X X
Busy schedule/domestic chores X X X
Ending support-food/lack of food support X X
Distance/access to preferred health facility X X X X X X
Slow service/long queues X X X X X
Limited counselling X X
Patient-provider relationships X X X X
Poor information by providers X X
Lack of case manager/availability of health providers X X X
Stigma associated with health facility X X X
Cost of treatment X X X
Lack of specialized treatment X
Lack of medication/availability of over-the-counter medication X X
Separate appointments for mother/child X
Drug packaging X
Competing interests from other NGOs X
Lack of partner support/discordance X X X X
Inadequate social support X X X X X X
Change in social status X
Media/peer influences X X
Lack of care in institutions X
Need Factors
Perceived health status X X X X X
Worsening health status/severity of illness X X X X X
Drug side effects X X X X
Long period of treatment/frequency of appointments/need for adherence X X
Treatment regimens X
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While they are trying other interventions, it takes time
for them to give up and come to the hospital…they dilly
dally at home as they try those other avenues and self
medicate, go to the church, go to the herbalist” (HCP,
Chulaimbo).
Enabling resources
Stigma was reported as a barrier for all categories with
the exception of retention in HTN care. Fear of being
recognized and discriminated against may deter an indi-
vidual from initially linking to care as one HIV positive
participant noted: “I am not going, I will be seen” (PLWH
FGD participant, Chulaimbo). The same is true for re-
tention, “…They fear to be seen by their neighbors and
will also disappear (all laugh).” (HCP FGD participant,
Turbo). While common for both linkage and retention
to HIV care, stigma was also encountered in other
chronic disease categories: “You know if you are dia-
betic…you are discriminated and this causes you not to
come to the hospital” (Caregiver FGD participant,
Chulaimbo).
A lack of finances was reported across all categories
except as a barrier for retention for HTN care. Specific
challenges were given related to the need for food “There
are some people for TB (pause) you know…when you are
using those drugs you need to eat well. A person may not
be having food…taking the drugs without the food
weakens a person and that is why some people leave
them” (CHW FGD participant, Turbo). Broader issues
with costs were also described “The patient is supposed
to come to the clinic on a monthly basis and it becomes
expensive for many” (HCP, Turbo). A religious leader
pointed to the larger issue: “…when somebody is poor it
becomes a silent killer…” (Religious Leader, Teso).
Busy schedules and domestic chores may act as a bar-
rier, particularly in the context of widespread poverty. In
particular, “Other competing factors at home may affect
appointments” (CHW FGD participant, Teso). This can
Table 3 Facilitators to Linkage and Retention to HIV, HTN and TB care
Linkage Retention
HIV HTN TB HIV HTN TB
Predisposing Characteristics
Personal initiative X X X X X X
Education X
Disclosure X X
Fear of losing a child/death/family responsibilities X X X X X
Belief in treatment/improved health X X X
Enabling Resources
Availability of education programs X X
Community awareness/sensitization (e.g., through sports) X X X
Comprehensive counseling/appropriate referrals X X X
Availability of free drugs/services/subsidized treatment X X X
Integrated services (including food services, TB-HIV) X X X X
Availability and training of healthcare providers X X
Accessibility of health facility X X X X X
Good provider-patient relationship X X X X X X
Provider maintains confidentiality X
Government collaboration/health policy X X
Follow-up care by CHWs for missed appointments X X X
Transport facilitation to health facility/physical access X
Economic empowerment X X
Peer-support testimonies/peer support X X X X X
Family/social support X X X X X X
Support from community leaders X
Need factors
Severity of illness X
Fear of restarting treatment X
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affect both linkage and retention particularly when con-
founded by financial challenges: “She looks for food for
the children. What can use for travel (to the clinic) in-
stead she uses for food” (CHW FGD participant, Turbo).
Employment may also interfere with an individual’s abil-
ity to be retained: “At times you might miss your ap-
pointment date due to working elsewhere. Most of us are
casual laborers so you might go to a place where you are
not close to a clinic” (Caregiver FGD participant, Turbo).
Distance/access to the health facility was reported as a
barrier for all diseases and as a barrier to both linkage
and retention: “…Distance and terrain of some places. If
a person has no means (pauses) reaching here is a prob-
lem.” (HCP, Chulaimbo). Distance to the clinic was par-
ticularly a challenge for individuals with financial
constraints: “You see, in the remote areas, transport to
get to the health facility could be an issue. It could be
Kenya shillings 100–300 on a motorbike. Most people
will not afford this” (HTN FGD participant, Turbo). A
long distance and poor access can negatively affect the
health of patient. The negative impacts of distance and
poor access were also described: “For TB (Pauses) people
who come from far and they are suffering from TB, the
distance covered is long and the patient will be tired”
(CHW FGD participant, Teso). Another explained that
the “…mama who has to walk for 6 or 7 km is too unfair”
(Religious Leader, Teso).
The distance to the clinic may be particularly a prob-
lem particularly when participants also have to deal with
slow service and long queues: “…One can wait for the
doctor from 6 am to 6 pm and does not see the doctor
after all that long wait” (HTN FGD participant, Turbo).
As one Caregiver noted, “If they come and realize that
the services are slow, they might get upset and go away,
never to return” (Caregiver FGD participant, Turbo).
Furthermore, the cost of treatment was reported as a
barrier for linkage and retention for HIV. The cost of
the drugs themselves was a barrier: “Drugs are expen-
sive” (HCP, Chulaimbo). Another participant noted that
“Some just lack money. There is no need to come to the
clinic because they have no money to buy drugs” (CHW
FGD participant, Turbo).
Patient-provider relationships were a commonly re-
ported factor affecting linkage and retention for both
communicable and non-communicable chronic diseases.
The nature of the relationship was described as being
particularly important “It also depends on health pro-
viders. The way they talk to us. You may get one who is
so good and talks to you so well but at time you may get
another one that is arrogant, harass you. You give up”
(HTN FGD participant, Teso). Many participants spoke
to issues with maintaining confidentiality: “…Health pro-
viders may know this client very well and we are human
beings. This provider may go home and expose the status
(i.e., HIV)” (HCP, Teso). When patients miss a visit or
are late for a visit, they fear to be scolded by their health
providers: “…There are those who start but stop along
the way. In most cases the health care providers contrib-
ute. Maybe the way they talk to you is bad. There was a
time I defaulted. I missed an appointment date for the
child so when I came the doctor was too harsh on me…I
went and stayed for some years…. So the manner in
which the doctor talks to the patient makes a lot” (Care-
giver FGD participant, Turbo). If a patient misses a visit
or is late for an appointment, the clinic staff may scold
them: “When you come late, you are told to go back and
add another year before you come. The health care pro-
viders chase you away” (Caregiver FGD participant,
Turbo). Another individual noted that: “health providers
are very strict on adherence and if you missed to take
medicines as required they are harsh on you and some
people fear that. If they have done such mistakes they
prefer staying at home” (PLWH FGD participant, Teso).
Stigma associated with the facility itself was reported
as a barrier to linkage and retention with “AMPATH be-
ing particularly associated with HIV” (PLWH FGD par-
ticipant, Teso). This may cause individuals to not link:
“Some just stay at home without seeking medical atten-
tion. Some have even passed on because they fear coming
to AMPATH” (PLWH FGD participant, Teso). Partici-
pants described their experiences and coping strategies:
“…in our clinic the CDM patients, hypertensive and dia-
betic, they queue with the HIV patients…when the pa-
tients are queuing, they want to tell their neighbour, the
next person, you know, I am not HIV+, I have a CDM
card (lots of laughs). And the next time, they won’t come
to the clinic because they are queuing with the HIV posi-
tives (HTN FGD participant, Turbo). Stigma associated
with AMPATH was not unique to patients as one
healthcare provider eluded: “Another problem is the
AMPATH thing. The community knows that anyone who
is found on the premises is HIV+. …even the staff” (HCP,
Turbo).
Need factors
The perceived severity of disease and symptoms experi-
enced may also influence whether an individual engages
in care. For example, an individual may not understand
or recognize disease symptoms: “… generally within the
Teso community they have not identified the symptoms
of TB or even know that TB is a killer… Most people who
have TB take it as a normal cough; others see it as a
chest problem… They deny TB as a name.” (Religious
Leader, Teso). “It’s only when people are critically ill to
the point that they cannot walk on their own that they
can decide to come to the health facility [Laughter]”
(HTN FGD participant, Turbo). This also speaks to an
individuals’ perceived health status: “Maybe one came
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when he was very weak and after using medication he
improves and thinks he is cured” (TB FGD participant,
Chulaimbo). Feeling better was a particular challenge for
retention: “when one improves he thinks he is healed and
stops coming to the clinic. He feels he is of good health”
(Traditional Healer, Chulaimbo).
This has implications for treatment effectiveness and
poor health outcomes: “....We have seen some patients
that when they take medicines their health improves and
they believe that they are now completely healed. They
leave medicines and for some time their health deterio-
rates and they come back to the clinic whereby some-
times they even die” (CHW FGD participant Teso).
Similar reports have been given for TB: “There are
some drugs like ones for TB. When you start using them
you feel dizzy and you might even collapse. Some patients
fear when they experience the side effects, then they stop
using drugs” (Caregiver FGD participant, Turbo). Related
to retention is the issue of having to take drugs long-
term: “There are some who fear coming for ARVS drugs
because they heard that once you start taking them, you
can’t stop for the rest of your life. They wonder and say,
‘Will I take these drugs till I die? This is stress and I
can’t’ [Laughter]. So there are people who fear taking
drugs” (PLWH FGD participant, Chulaimbo).
Lack of partner support/discordance was reported as a
barrier to linkage to TB care and was reported across
disease categories as a barrier to retention: “A lack of
support from partners matters. My husband said to me,
‘You die with your pressure so that I re-marry. What are
you still doing? Just die’ [Laughs]. It is not until I looked
for my own money that I came to the hospital” (CHW
FGD participant, Teso). Fear of being blamed, in the
case of HIV, also was brought up: “It is an issue among
youth and couples…especially when one partner is tested,
when she goes back home, she doesn’t know whether the
partner is positive or negative so she decides to keep quiet
because if she says anything, it will be concluded that
maybe she is the one who brought it.” (HCP, Teso). One
caregiver noted that without proper support from one’s
partner, retention in care is a challenge: “You may not be
able to meet all your needs or the husband might not be
supportive. You then decide to stop treatment and sit
back” (Caregiver FGD participant, Teso).
Inadequate social support, more generally was a com-
monly reported barrier. In some cases, this can affect
whether an individual is able to get to the clinic: e.g.
“some have been identified but they are too weak but
can’t get somebody to accompany them to the hospital”
(HCP, Chulaimbo). Inadequate support may also lead an
individual to not get better particularly if there is no one
to help take care of them or remind them to take their
drugs: “there are some children who are HIV positive
and quite a good number of them are orphans so it is a
caregiver who takes care of them….and to some extent
the condition of the child is worse and if the caregiver
doesn’t have a heart to take care of that child, he/she be-
comes fatigued and stops bringing the child for care”
(HCP, Chulaimbo). Furthermore, challenges within
households can also present challenges: “In some fam-
ilies there is a lot of violence that sometimes discourages
a woman to continue with drugs” (Religious Leader,
Chulaimbo).
Facilitators
In general, there were fewer facilitators compared to bar-
riers and most facilitators were reported for linkage to
HIV care.
Predisposing characteristics
While poor motivation was a barrier to linkage and re-
tention, having a strong personal initiative was reported
as a facilitator to linkage and retention for all disease
categories. In terms of linkage, taking responsibility for
one’s health can drive individuals to seek out care as one
participant noted: “I think it is personal responsibility.
People are concerned about their health and they have
realized that chronic diseases like hypertension and dia-
betes are not diseases of the rich - Anybody can get it. So
they are coming to the clinic because they are concerned.”
(HCP, Turbo). One patient further noted that “people
like us who want our health to be prolonged, come
here…” (PLWH FGD participant, Teso). Personal initia-
tive was also described as a facilitator to takings medica-
tions as prescribed: “In my opinion, it is very important
for me to take drugs because if I don’t, I might die. It is
better to take good care of my health by completing the
dose as instructed by the doctor” (TB FGD participant,
Chulaimbo).
A belief in treatment, and in AMPATH, was also an
important facilitator. In terms of linkage, an individual
may come for care “because they are assured that his
health being taken care of. Then AMPATH has been on
the ground for long and people are aware of the services
offered.” An improvement in health also works to facili-
tate retention. As one traditional healer noted: “Once
people start using the medication, they improve. The fact
that TB is treatable motivates people to come for treat-
ment” (Traditional Healer, Chulaimbo).
Family responsibilities and fear of losing a child were
common facilitators to linkage for all disease categories
and for retention to HIV and TB care. “Another reason
is that we have children at home that depend on us. You
do not wait to get wasted until you are not able to pro-
vide for your family” (HTN FGD participant, Teso). It
was also important to protect children from getting sick:
“so when you come here you are told if you take your
child to clinic you can save your child from getting HIV…
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Like me I fear to lose a child like I did, he was my first
born (Caregiver FGD participant, Teso).
Enabling resources
These were the most common type of facilitators for
linkage and retention to care. Good provider-patient re-
lationships were the most commonly reported facilitator
to care: “There was a time when patients were picked
from their homes to the hospital. When one fails to come
to the clinic, he is followed up. The healthcare providers
love the patients and this motivates them to come for
care” (Traditional Healer, Chulaimbo). Being treated
with respect was important for patients: “Staff are warm.
They help with counseling from testing through to treat-
ment” (PLHW FGD participant, Teso). Related to this is
how patients are spoken to: “the nurse who gives us
medication talks to us nicely. I don’t know whether I am
the only one she talks to well but she treats me so well.
She asks me several questions concerning my health be-
fore she gives me the drugs” (TB FGD participant,
Chulaimbo).
Accessibility of the health facility was also reported as
a facilitator. Bringing services to the community was
noted: “AMPATH brought very good services to Chu-
laimbo” (Religious Leader, Chulaimbo). Proximity to
one’s home is also an important facilitator: “Personally, I
am very happy coming here because it’s a clinic next to
our homes, expenses have been reduced. I commend
AMPATH for that. It has made it possible for us to at-
tend the clinic on a regular basis” (HTN FGD partici-
pant, Turbo). Another noted: “I enrolled here because it
was near” (TB FGD participant, Teso).
The provision of integrated services was cited as a fa-
cilitator to care for HIV and TB linkage and retention.
Including food services was particularly important: “We
also have these patients who will feel like for sure they
have been helped for the six months they participated in
the food program and they feel appreciated and they will
come back to the clinic, because they say that they were
helped at the time of need” (HCP, Turbo). This was par-
ticularly important context of widespread poverty: “Free
food especially at this time of famine. There is no food at
home and you are so weak that you cannot provide for
yourself. You don’t care even if people see you at
AMPATH it is about the disease. It is not your choice.
These people are very good. If you call, them the driver
just brings you food or they make follow ups to see how
you are doing” (CHW FGD participant, Teso). The inte-
gration of TB-HIV care was also seen as positive: “OK,
for TB patients, since the integration of the TB/HIV
clinic… the number of TB patients coming to the clinic is
steadily rising and also the retention of these clients is
perfect and the adherence to medication is good. So I
think I can relate this to the kind of services we are
offering, that it is centered to one person who is always
available to attend to the client” (HCP, Turbo).
Related to this are the services available: “Some clients
told me that they go to other health facilities where
weight is only checked and given ARVs. AMPATH takes
all the vitals, tests blood pressure, pulse, weight and
temperature (pauses)…everything. It gives very good
drugs” (PLWH FGD participant, Chulaimbo). The
provision of free/subsidized services was also described
as a facilitator: “It’s a place where they can get drugs at
the revolving pharmacy; the prices are lower compared to
the prices they pay with in chemists in town” (HCP,
Turbo).
Peer support/testimonies and family and social sup-
port were reported facilitators for the majority of cat-
egories with the latter being an important facilitator for
linkage and retention in all disease categories. The role
of peer testimonies and improvements in health could
work to influence individuals to link with care: “I had a
friend that was wasted and people never thought that he
would recover but I met him afterwards. He was so
healthy and was able to do his work. He gave me coun-
selling and that is how I got to come to the hospital”
(HTN FGD participant, Teso). It could also work to en-
courage one’s own acceptance of their illness and it
many ways they “themselves become the facilitators”
(Traditional healer, Chulaimbo). Another participant
noted that “It helps… Because it encourages, you talk
about some issues (pause). You encourage each other”
(CHW FGD participant, Turbo). Peer testimonies can
help individuals to disclose their own status: “....I joined
a support group where I got to know how to disclose after
counselling. If you want to live long with HIV (pauses)
you talk about. Don’t keep it for yourself”, I was told”
(PLWH FGD participant, Chulaimbo).
Family and social support can help individuals to
come to terms with their illness and link to care: “If
there is no improvement, his own people will advise
him to go to the hospital” (Traditional Healer, Chu-
laimbo). Social support also works to encourage posi-
tive behaviors that are important for maintaining
one’s health: “Yes, you must be given time to think
and make a personal decision. I was tested and given
one week to go and think over it. My mother really
encouraged me” (PLWH FGD participant, Chulaimbo).
As some participants noted, it can depend on the
family: “If the family understands then you will not
suffer a lot of trauma” (PLWH FGD participant,
Teso). Importantly, children and families could also
remind patients to take their medications: “When I’m
held up with some domestic chores my children re-
mind me that have you taken drugs? “I have heard or
I’m going to take them now I do reply”’ There is sup-
port” (HTN FGD participant, Teso).
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Need factors
Severity of illness and fear of restarting treatment were
two need factors considered as facilitators to linkage and
retention to TB care, respectively.
Discussion
Enabling resources as barriers were the most commonly
reported factors affecting linkage and retention. In
addition to adding to the literature, our findings provide
additional insight on common barriers and facilitators
that can deter or encourage linkage and retention across
multiple chronic diseases. Importantly, the number of
comorbid conditions is rising in LMICs when an in-
creasing number of individuals managing more than one
chronic condition that requires continuous engagement
in care [8, 25]. The findings of the present study high-
light facilitators and barriers that are common across
chronic diseases and can inform interventions that con-
sider the logistical factors that can facilitate or inhibit
engagement in care.
Many predisposing factors could be either a barrier
(e.g., poor motivation) or a facilitator (e.g., personal ini-
tiative) depending on the situation and/or context. Atti-
tudes including self-efficacy and beliefs in treatment
effectiveness have been shown to be important for ad-
herence to care and treatment and successful self-
management of one’s illness [32–34]. Attitudes towards
engagement in care can be influenced by other factors
such as knowledge/or lack of knowledge about the dis-
ease and treatment options as well as the need for ad-
herence [34–37]. In addition, while believing in
treatment effectiveness can lead to positive health seek-
ing behaviours [38], an improved health and the belief
that treatment is no longer necessary can be a barrier to
care.
Patient-provider relationships are an enabling resource
that can be both a barrier and facilitator, depending on
the nature of the interactions. The importance of these
relationships and its role in retention in care [33, 39],
has been well studied in high income settings [40–42]
and in recent years, its importance, in LMICs, has
emerged. Consistent with other studies [33, 43–45], our
findings identified specific aspects of patient-provider re-
lationships that can impact on engagement in care in-
cluding issues with maintaining confidentiality. The use
of rough or exposing language by healthcare workers
has been shown to be an important reason for disen-
gaging from HIV care [46, 47]. The fear of being yelled
at if missing a visit has been shown to be a strong pre-
dictor for feeling reluctant to return to the clinic [47]. A
recent study from our setting suggests that perceived
physician communication behaviours are associated with
adherence to HIV care [48]. Physician trust has been
previously been associated with adherence to diabetes
management [49, 50] and a trusting patient-provider re-
lationship has also been associated with improved HIV
testing for patients with TB [51] and improved chronic
disease management more generally [52]. Sensitization
training for healthcare workers should include strategies
to improve communication and interpersonal skills to
build patient trust and encourage long term engagement
in care.
Interestingly, while individual predisposing character-
istics, enabling resources and need factors were reported
as barriers or facilitators, it is likely combinations of
these factors work together in a complex sequence of
events [47]. For example, in the case of HIV, disclosure
of one’s status has been recognized as a double-edged
sword [53], having the potential to yield needed social
support but can also result in stigmatization/abandon-
ment [53–56]. In the present study, this extended to be-
liefs about stigma associated with the health facility. The
labelling of AMPATH as an HIV organization can dis-
suade individuals from seeking care for other conditions
like hypertension. Importantly for patients who chose to
go to care elsewhere due to a fear of being recognized at
a clinic closer to home, this may mean that they have to
travel further to receive care. This can result in higher
transport costs [46, 57–60]. However, while retention
can be improved when care is closer located closer to
patient homes [57, 61–64], individuals continue to face
numerous challenges and complexities when negotiating
care; these need to be addressed and considered in inter-
vention/strategic planning.
The integration of care and treatment services across an
array of diseases may be a vital strategy to encourage en-
gagement in appropriate care especially given that similar
self-management skills are needed across chronic diseases
[15]. Making a range of services available in one place, in-
cluding food support and education programs, can help to
simplify care and treatment [14] and facilitate engagement
for those who may have otherwise not linked as was dem-
onstrated in this study. While there the goals of integrative
programs may vary with disease-specific needs, broadly
they seek to support self-management skills, medication
adherence, coping skills and the promotion of self-efficacy
[15]. AMPATH’s Bridging Income Generation with
Provision of Incentives for Care (BIGPIC) uses an inte-
grated approach to address barriers specific to socioeco-
nomic status for individuals living with diabetes and
hypertension and works to improve positive health seek-
ing behaviours. While useful, integrated approaches re-
quire continuous evaluation to explore their acceptability
and identify potential negative impacts (e.g., not wanting
to be identified as HIV positive if queuing in the same
line). Furthermore, programs should be targeted and tai-
lored for specific contexts and settings [15] and support
individuals with logistical and financial challenges [56].
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Social support was a facilitating enabling resource for
linkage and retention to care. Family influences [34, 65]
have been shown to be important predictors of adherence
to care and treatment [34, 36, 66–68]. The desire to be alive
and be able to support their families and see their children
grow up is a strong motivator for patients [69, 70]. Family
members are an important source of support [65, 71, 72]
and given that a large proportion of illness care takes place
in the home [73], remains one of the most important sup-
porting mechanisms for individuals living with chronic dis-
eases [73–75]. There is a need to further elucidate the type
and nature of familial relationships that work to encourage
engagement in care. At the same time, the health and well-
being of family members and caregivers supporting individ-
uals with chronic diseases can also be affected [72, 73, 75–
79], suggesting that strategies that address the burden on
caregivers (e.g., psychosocial support) are also needed.
Participants also identified peer support as a facilitator to
care. In addition to developing a supportive connection
with individuals with similar lived experiences, peer support
can improve adherence to treatment [67, 78], promote self-
management [80], coping skills and problem solving [14],
reduce experiences of stigma and isolation [81], improve
beliefs in treatment, self-efficacy [82] and feelings of hope
[67, 72]. Peer support groups are common across many dis-
eases and have been shown to have positive impacts on
clinical and social outcomes. In diabetes management for
example, peer support has resulted in decreases blood pres-
sure while improving contact with the healthcare team and
overall self-management [83, 84]. The use of peer naviga-
tors in the HIV literature has shown to improve access to
care including retention in care as well as improving ac-
ceptance of one’s status and disclosure [85, 86]. Import-
antly, peers may be more approachable than healthcare
providers. In Malawi for example, patients living with HIV
noted that in addition to being reliable sources of support
and essentially acting as role models, expert patients are
better able to understand them and respect confidentiality
compared to other types of health workers [87].
There are a few limitations worth noting. This was a
qualitative study and we acknowledge that our findings
cannot be generalized to the wider Kenyan population. It
mainly presented views of communities studied and was
limited to perceptions about AMPATH health facilities.
There may be other barriers and facilitators that were not
captured but that are relevant for linkage. Furthermore, in
the present study only patients who had linked and engaged
in care were included. Importantly, individuals who did not
link to care may be different and have different perspectives
on the key barriers and facilitators to linkage and retention.
Conclusions
We qualitatively explored barriers and facilitators to en-
gagement in HIV, TB and HTN care in western Kenya.
Numerous factors were consistent across disease cat-
egories including the importance of personal drive and
patient-provider relationships. Future research should
work to identify other barriers and facilitators that may
be common to linkage and retention across diseases as
well as evidence-based strategies to support timely en-
gagement in care while considering logistical and finan-
cial barriers. Integrated service delivery for chronic
diseases, may offer once such strategy given the increas-
ing prevalence of NCDs among the general population
and among those living with HIV although such models
should be rigorously evaluated.
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